Reuters rounds up Wall Street reactions as Lilly stock jumped about 7.5%. Analysts point to the oral drug Foundayo's launch as the thing to watch.
Recap by typeshit. Full story at Central Oregon Daily.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
After "Ozempic face" and "Ozempic butt," social media users are coining yet another term for a GLP-1 side effect. Light on detail beyond the trend.
A buyer's guide comparing online tirzepatide providers. It's an affiliate-style roundup more than news, so read it with that in mind.
Loading…